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proved to be superior because most studies have a limited
cohort size as a result of the low prevalence of this dis-
ease. Furthermore, several reports lack objective follow-
up data and have based their life-table patency solely on
clinical observations, which may underestimate the inci-
dence of graft thrombosis and stenosis.2,3,5
Revascularization traditionally involves antegrade or
retrograde bypass grafts originating from the supraceliac
or infrarenal aorta with a transabdominal approach. In
cases where abdominal disease or prior surgery would ren-
der a difficult transperitoneal exposure, the distal thoracic
aorta (DTA), which is relatively free of atherosclerosis,
may provide a better inflow source. The purpose of this
report is to evaluate the results with the DTA used as
inflow for the surgical treatment of CMI.
PATIENTS AND METHODS
From 1990 to 1999 all patients undergoing mesen-
teric revascularization for CMI with grafts originating
from the DTA were identified from the Vascular Surgery
Operative Database at the University of North Carolina.
Patient demographics and procedural characteristics were
obtained from hospital records. Angiography was per-
formed and available for review in all patients. Mesenteric
vessels were characterized as being stenotic if > 50% steno-
sis existed. The status of the internal iliac arteries was doc-
umented when angiographic evaluation was available.
Patients were positioned in the right lateral decubitus
orientation after intubation with a double lumen endotra-
cheal tube (Fig 1). If access to the iliac or femoral vessels
During the past two decades numerous publications
have reported the merits of various methods of revascu-
larization for chronic mesenteric ischemia (CMI).1-5
Controversy centers primarily around two issues: the mer-
its of antegrade versus retrograde bypass grafting in pro-
viding optimal revascularization and the need for
complete revascularization to reduce the risk of recur-
rence. In 1981 Hollier et al3 popularized the concept of
complete revascularization, proposing that, by reestab-
lishing blood flow to all diseased vessels, the risk of recur-
rent symptoms and associated complication related to
graft thrombosis or stenosis was reduced. In distinct con-
trast Gentile et al6 believe that isolated retrograde bypass
grafts to the superior mesenteric artery (SMA) provide
comparable results and long-term prevention of recur-
rence. Antegrade bypass grafts theoretically provide the
best flow characteristics and may minimize the risk of
kinking that has been proposed as a mechanism of peri-
operative thrombosis. To date, no method has been
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Distal thoracic aorta as inflow for the treatment of
chronic mesenteric ischemia
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Purpose: Mesenteric revascularization for chronic mesenteric ischemia (CMI) traditionally involves antegrade or retro-
grade bypass graft originating from the supraceliac or infrarenal aorta. The distal thoracic aorta (DTA) may provide a
better inflow source than the abdominal aorta. The purpose of this study was to evaluate the results with the DTA used
as inflow for the surgical treatment of CMI.
Methods: All patients undergoing mesenteric revascularization for CMI with grafts originating from the DTA were iden-
tified from 1990 to 1999. A ninth interspace thoracoretroperitoneal incision was used for exposure, and distal aortic
flow was maintained by use of a partial occlusion clamp.
Results: Eighteen consecutive patients with CMI underwent mesenteric bypass grafting with the DTA used as inflow.
All patients were admitted with chronic abdominal pain or weight loss, with two (12%) requiring urgent revascular-
ization because of acute exacerbation of chronic symptoms. Fourteen (78%) patients had both celiac and superior
mesenteric artery bypass grafts placed, and three (17%) patients had superior mesenteric artery grafts alone. There was
one (6%) perioperative death and three (17%) major complications. There was no kidney failure, mesenteric infarction,
or spinal cord ischemia. The life-table survival rate was 89%, 89%, and 76% at 1, 3, and 5 years, respectively. All 18
patients remained symptom free and required no additional procedures to assist patency. There was no evidence of graft
stenosis or occlusion (100% patency) for those grafts evaluated objectively during the mean follow-up of 34.8 months
(range, 1-97 months).
Conclusions: Antegrade mesenteric revascularization with the DTA used as inflow is associated with low morbidity and
mortality rates. Furthermore, it provides excellent midterm patency and survival results and should be considered as a
primary approach for reconstruction of patients with CMI. (J Vasc Surg 2001;33:281-8.)
was required, then the pelvis was rotated at approximately
60 degrees. A bean bag and axillary roll were routinely
required to aid in positioning. A ninth interspace thora-
coretroperitoneal incision was used to expose the thoracic
and upper abdominal aorta. Mobilization of the peri-
toneum and its contents from the undersurface of the
diaphragm was performed bluntly. The diaphragm was
incised in a curvilinear fashion 2 cm from its costal edge to
preserve innervation and with marking stitches to improve
reapproximation. The inferior pulmonary ligament was
divided, as well as the crus of the diaphragm. The celiac
and superior mesenteric vessels were exposed until a suit-
able bypass graft site was obtained (Fig 2). If required, 8
to 10 cm of vessel can be exposed. The left kidney was left
undisturbed in its native position to facilitate distal expo-
sure of the SMA. A partial occlusion clamp technique was
used to maintain distal aortic flow to the kidneys and
spinal cord (Fig 3). The proximal anastomoses were per-
formed with a single clamp application to minimize
repeated trauma to the thoracic aorta. Prosthetic bypass
graft conduits were used and routed through the
diaphragmatic hiatus to their respective vessels in an end-
to-side fashion to establish antegrade flow (Fig 4).
Patients revascularized after January 1996 were moni-
tored prospectively and underwent objective documenta-
tion of patency before discharge with computed tomogra-
phy, magnetic resonance angiography (MRA), or duplex
scan evaluation. Duplex ultrasound scanning was initiated
at the 4-month follow-up visit and performed every 6
months to 1 year thereafter to detect graft stenosis. Most
studies were obtained on patients in a fasting state. If a
technically inadequate or nondiagnostic study result was
obtained, an MRA was performed to assess graft patency
along with the degree of stenosis. Patients undergoing
revascularization before 1996 underwent follow-up with
sequential duplex ultrasound scanning over the past 3
years. Stenosis criteria were based on elevated diastolic
velocities greater than 45 cm/s for the SMA and 55 cm/s
for the celiac artery (CA) bypass grafts.7 Additional follow-
up information was obtained with subsequent office visits.
Complete revascularization was defined as establishment of
antegrade flow in all diseased vessels.
Statistical analysis was performed with Kaplan-Meier
life-table analysis, with significance established at an overall
level of P less than .05. Values are expressed as a mean ± SE. 
RESULTS
Eighteen consecutive patients with CMI underwent
mesenteric bypass grafting with the DTA used as inflow
and represent the entire institution’s experience. The aver-
age age at operation for this cohort was 64.4 years (range,
36-79 years), with all but one (94%) patient being a
woman. All patients were white and were admitted with
abdominal pain or weight loss (Table I). The pathophysi-
ology involved atherosclerotic occlusive disease in 16
(89%) patients and Takayasu’s arteritis in two (11%). Two
patients required urgent revascularization because of acute
exacerbation of chronic symptoms. The average time for
diagnosis was 10.3 months (range, 2-24 months), and in
the 15 patients reporting weight loss, the average was 18.3
kg (range, 9-45 kg) during this period. Significant risk fac-
tors are listed in Table II and are notable in that 83% had
significant tobacco use, and none of the patients had dia-
betes. Five prior vascular procedures had been performed
in four patients and included carotid endarterectomy (n =
3), aortobifemoral bypass graft (n = 1), and femoro-
femoral bypass grafting (n = 1). All but three patients
(83%) had prior abdominal surgery, which involved chole-
cystectomy in 44% of the patients and intestinal resections
for nonischemic indications in three patients (17%).
One-, two-, and three-vessel involvement occurred in
6%, 50%, and 44%, respectively, and is depicted in Table
III. None of the patients had isolated involvement of the
CA or inferior mesenteric artery (IMA). Twelve of 18
patients had angiographic evaluation of their internal iliac
arteries. Unilateral disease was present in six patients
(50%), and bilateral internal iliac occlusive disease was pre-
sent in five (42%). Twenty-two percent of the patients had
both IMA stenosis and bilateral internal iliac stenosis.
Thirty-three vessels were reconstructed and included
CA and SMA reconstruction in 15 patients (83%) and iso-
lated SMA revascularization in three (17%) (Table III).
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Fig 1. Patient positioned in right lateral decubitus position before
undergoing thoracomesenteric bypass grafting. Dashed line shows
intended location of incision.
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Fig 2. Exposure of DTA and upper abdominal aorta through thoracoretroperitoneal incision.
Fig 3. Partial occlusion clamp placed on DTA. Proximal graft anastomoses of individual grafts depicted.
Fig 4. Graft orientation through diaphragmatic hiatus to CA and SMA.
None of the patients had revascularization of their IMA.
An adequate distal end point could not be obtained in one
patient with an occluded CA and was not revascularized;
however, the IMA was patent without evidence of disease.
Complete revascularization was performed in 44% of the
patients. Bifurcated graft configurations were used in three
patients with parallel straight grafts used for the remainder
of the patients requiring multiple vessel revascularization
(Fig 4). Bifurcated grafts were used in our early experi-
ence; however, this has been abandoned for a parallel
straight graft configuration, which allows for better graft
orientation and routing through the diaphragmatic hiatus.
Ringed polytetrafluoroethylene was the conduit chosen in
32 (94%) of the grafts, and polyester fiber (Dacron) in
one. On the basis of distal vessel caliber, graft size was 8
mm and 6 mm in 11 (33%) and 22 (67%) of the bypass
grafts, respectively. Proximal thoracic aortic endarterec-
tomy was never necessary. Both proximal and distal recon-
struction used end-to-side anastomosis, and only two
patients required distal endarterectomy to achieve an ade-
quate revascularization. Concomitant vascular procedures
were undertaken in five patients. In three patients with
coexisting severe claudication, thoracobifemoral bypass
grafting was performed, and two patients underwent left
renal artery bypass grafting for severe left renal artery
stenosis and malignant hypertension.
Operative time averaged 343 minutes, and partial
clamp time was 27 minutes, with an average blood loss
of 625 mL. Ten of the 18 patients were extubated at the
completion of the procedure, whereas the remaining
eight remained intubated for an average of 3.3 days
(range, 1-8 days). There was one perioperative death
(6%) resulting from multisystem organ failure (MSOF).
In this patient, both bypass grafts were patent on post-
operative computed tomography imaging. Major com-
plications developed in three additional patients (17%)
and included two myocardial infarctions and one respira-
tory failure requiring short-term reintubation. Six minor
complications occurred: arrhythmias (n = 2), uncompli-
cated pancreatitis (n = 1), Clostridium difficile colitis (n
= 2), and upper extremity rest pain caused by subclavian
stenosis (n = 1). Of note, there was no kidney failure or
spinal cord ischemia. Excluding the patient with a pro-
longed hospital course caused by MSOF, the mean
length of stay was 11.5 days and was increased to 13.3
days when all patients were included.
All patients remained clinically symptom free and
required no additional procedures to assist patency during
the mean follow-up of 34.8 months (range, 1-97 months).
The life-table survival rate was 89%, 89%, and 76%, at 1, 3,
and 5 years, respectively (Fig 5). Three patients died of
unrelated causes and included lung cancer (n = 2) and
myocardial infarction (n = 1). One of the patients died at
3 months before undergoing any objective follow-up.
Objective data were obtained in 13 of the 16 patients sur-
viving longer than 4 months. Two of the three remaining
patients died of the aforementioned causes before obtain-
ing objective documentation at 42 and 61 months after
operation. The third patient has declined objective evalu-
ation but remains clinically symptom free at 65 months.
Of those patients undergoing objective evaluation, duplex
scanning was diagnostic in 12 patients (92%), and MRA
was diagnostic in the 13th. There were no focal elevations
in diastolic graft velocities, and all bypass grafts (100%)
evaluated objectively remain patent.
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Table II. Risk factors for 18 patients undergoing 
thoracomesenteric bypass grafting
Risk factors No. of patients (n = 18)
Smoking 15 (83%)
Diabetes 0
CAD 8 (44%)
Angina 2 (11%)
MI 4 (22%)
CHF 3 (17%)
PTCA 1 (6%)
CABG 3 (17%)
Stroke 1 (6%)
Hypertension 15 (83%)
Hyperlipidemia 5 (28%)
Renal insufficiency 3 (17%)
COPD 6 (33%)
Hypercoagulable 0
Prior vascular surgery 4 (22%)
CAD, Coronary artery disease; MI, myocardial infarction; CHF, congestive
heart failure; PTCA, percutaneous transluminal coronary angioplasty;
CABG, coronary artery bypass grafting; COPD, chronic obstructive pul-
monary disease.
Table I. Presenting symptoms for 18 patients undergoing
thoracomesenteric bypass grafting
Presenting symptom No. of patients (n = 18)
Abdominal pain 14 (78%)
Weight loss 15 (83%)
Pain or weight loss 18 (100%)
Pain and weight loss 11 (61%)
Table III. Distribution of involved vessels for 18
patients undergoing thoracomesenteric bypass grafting
Vessel involved No. of patients (n = 18)
Celiac 16 (89%)
SMA 18 (100%)
IMA 9 (50%)
Right hypogastric 2 (11%)
Left hypogastric 4 (22%)
Both hypogastric vessels 5 (28%)
Celiac, SMA, and IMA 8 (44%)
Celiac and SMA 8 (44%)
Celiac and IMA 0
SMA and IMA 1 (6%)
SMA only 1 (6%)
IMA and bilateral hypogastric 2 (22%)
DISCUSSION
Even though the prevalence of atherosclerosis in the
visceral vessels ranges from 6% to 24% in autopsy
reports,8,9 CMI is an infrequently encountered clinical
occurrence. It has been postulated that the clinical syn-
drome rarely exists because of an excellent intestinal col-
lateral circulation.10-12 In spite of this, patients with
single-vessel occlusive disease may be admitted with
CMI, which typically involves the SMA.13,14
For surgical correction of CMI, nearly all exposures use
a transperitoneal midline incision. Stoney et al4 advocate
transaortic endarterectomy or antegrade bypass grafting
from the supraceliac aorta with medial visceral rotation.
With these techniques he and his colleagues have achieved
97% 1-year and 86% 5-year patency rates, with complica-
tion rates being higher for the transaortic endarterectomy
group (17% vs 0%, P = .03).4,15,16 Taylor et al13 prefer ret-
rograde bypass graft from the infrarenal aorta because of its
familiar exposure and reduced risks with clamping and dis-
section. They have avoided kinking by careful attention to
graft configuration and have achieved a 5-year patency rate
of 96% with an operative mortality rate of 7%.13 Johnston
et al17 treated 34 patients with antegrade or retrograde
bypass grafts and noted 1- and 5-year survival rates of 100%
and 86%, respectively. Of note, 19% of these procedures
were performed through a thoracoabdominal incision;
however, no specific details or analysis was given. More
recently a transabdominal thoracoabdominal approach was
reported as being well tolerated, although no critical eval-
uation of results was reported.18
Hollier et al3 have stressed the importance of per-
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forming complete revascularization, so that single-graft
thrombosis does not result in bowel infarction. The recur-
rence rate was reduced from 50% to 17% by use of this
technique. The mortality rate and long-term results of the
procedure can be improved by limiting the complications
associated with mesenteric revascularization.
We have a significant experience with the descending
thoracic aorta for lower extremity revascularization and
have found it to be relatively free of atherosclerotic dis-
ease.19,20 In addition, the incision is well tolerated without
significant pulmonary or other complications. As a result,
we have expanded its use as an inflow source for mesen-
teric revascularization. In our group of 18 patients, as in
other published series, there was a propensity toward
female patients without diabetes and with a history of
smoking.17,18,21-23 However, our white race distribution
(100%) is an unusual finding and has not been observed
previously in the literature. Furthermore, nearly half of
this population (44%) had undergone cholecystectomy
before visceral revascularization. It is unclear whether this
was truly the result of gallbladder ischemia or simply due
to the increased incidence of cholecystectomy for gall-
bladder disease since the advent of laparoscopy.
Thoracoretroperitoneal revascularization provides sev-
eral technical advantages. A thoracoabdominal incision
allows for easy exposure of the thoracic and abdominal
aorta, and, when necessary, concomitant procedures can
be performed for renal and lower extremity revasculariza-
tion. It is, however, more difficult in patients who have
undergone prior left chest surgery. Because the DTA is
rarely diseased, partial occlusion is possible, thereby reduc-
Fig 5. Life-table survival of 18 patients undergoing thoracomesenteric bypass grafting.
ing the potential for renal and spinal cord ischemia associ-
ated with supraceliac clamping. Even in debilitated
patients, the incision is well tolerated, allowing discharge
at an average of 13.3 days, which compares favorably with
other studies.18,23 Potential criticism for this approach
could include the inability to adequately expose a distal
patent vessel for revascularization. This occurred in one
patient who could not have the CA revascularized. This
patient has done well with SMA revascularization alone,
suggesting that adequate collateral vessels exist between
the SMA and CA in many cases, allowing for successful
single-vessel reconstruction. If necessary, the splenic artery
can easily be dissected from within the peritoneum and
antegrade revascularization performed.
In spite of widespread distribution of atherosclerosis in
the visceral vessels, only 17% of our patients had previous
and 28% concomitant vascular procedures performed. The
SMA was involved in all patients and the CA in 89%.
Although complete revascularization has received much
attention in the literature,3,22,24,25 our approach has been to
reestablish blood flow only to diseased SMA and CA vessels
(> 50%) and not base operative strategies on the status of
the IMA. With this strategy complete revascularization was
performed in 44% of the cases. In spite of the presence of
combined IMA and bilateral internal iliac artery stenosis in
22% of the patients, recurrent symptoms did not develop,
even though the IMA was never revascularized.
Our operative mortality rate (6%) correlated well with
that reported by most previous studies17,23,26 and was
associated with MSOF as others have reported.22,26,27
Given the malnourished nature and comorbid conditions
present in this population, further reduction of this rate
may be difficult. Of note, several studies have emphasized
the grave prognosis and high mortality rate associated
with perioperative graft thrombosis,3,23,24,26,28 which did
not occur in our study.
During our mean follow-up of 34.6 months, no
patient had development of recurrent symptoms or steno-
sis on the basis of objective follow-up. When the DTA is
used as inflow, our midterm results suggest that patient
survival, not graft patency, is the limiting factor. Because
only antegrade bypass grafts were performed, comparison
with retrograde bypass grafts must be based on historical
data, which have been published early and include late fail-
ure rates in the range of 0% to 15%.17,23,24,26 By provid-
ing antegrade bypass grafts from the DTA, we think that
the tendency for graft kinking is reduced and the propen-
sity for thrombosis caused by progression of atheroscle-
rotic inflow disease is minimized. Also, the short nature of
these antegrade bypass grafts may allow for partial or com-
plete endothelialization of the grafts decreasing the
propensity toward thrombosis.
In conclusion, antegrade mesenteric revascularization
with the DTA used as inflow was associated with an
acceptable mortality and morbidity rate in this debilitated
group of patients. Furthermore, it provides excellent
midterm patency and survival results that were not associ-
ated with either early or late thrombotic complications.
The results were not influenced by the completeness of
revascularization, and life expectancy was limited by other
comorbid conditions. We think that this technique should
be considered as a primary approach for reconstruction of
patients with CMI.
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DISCUSSION
Dr K. Wayne Johnston (Toronto, Ontario). Dr Porter, mem-
bers, and guests.
This paper presents data that support my personal view that
complete mesenteric revascularization using grafts that run in a
straight line from the thoracic aorta or perhaps supraceliac seg-
ment is the optimal approach. However, it is crucial, as the authors
fairly point out, to note that other reports have had equally satis-
factory results, including single grafts from the abdominal aorta,
balloon angioplasty, and transaortic endarterectomy.
This is the first large reported series of thoracomesenteric
grafts. The authors report excellent results: one death in 18
patients, 75% 5-year survival, and no late deaths from mesenteric
ischemia. That’s commendable. These excellent results are, how-
ever, similar to the other techniques that I mentioned.
The average operative time was 5.5 hours. The following
technical comments may be worth considering. First, a double
lumen endotracheal tube is actually not necessary, since the expo-
sure of the distal thoracic aorta is all that’s required. Our anes-
thetists take extra time inserting a double lumen tube.
The diaphragm does not need to be divided as extensively as
suggested by the authors. Just divide enough to allow the ribs to be
separated and the thoracic aorta in the lower segment to be exposed.
This simpler approach might have prevented the prolonged intuba-
tion that was required in eight of the 18 patients in this study.
In performing the proximal aortic anastomosis, a partial
occluding clamp presumably allows distal flow; however, in my
experience, a partial occluding clamp usually compromises distal
flow and makes what is otherwise a simple anastomosis more dif-
ficult. It’s often easier to simply cross clamp the aorta and expe-
ditiously perform the proximal anastomosis. If two grafts are
performed as noted in the figure, the authors anastomose both of
them to the aorta rather than simply taking the second graft off
the side of the primary graft.
This excellent series and the other reported series in the lit-
erature are all very small. Consequently, no definite conclusions
can be reached on the optimum method of mesenteric repair, and
no data can support one’s bias. I suspect that personal preference
and experience with one technique may be the most important
deciding factor in what technique you use.
Thank you.
Dr Mark A. Farber. Dr Johnston commented on the fact that
double lumen endotracheal intubation is not necessary in all
patients. That is exactly correct. However, it does give you more
latitude if you have it in. If it’s not needed, you do not have to
clamp that left lung.
He also commented that, in his opinion, it may have affected
our average intubation. Ten of the 18 patients were extubated at
the completion of the procedure. The remaining eight patients
had an average intubation of 3.3 days, and that includes the
patient who was intubated with multisystem organ failure for long
duration. So I don’t think that it affects it significantly.
What we have done is exactly what you mentioned. I did
show a slide in which the diaphragm is left intact. If you don’t
want to take the diaphragm all the way down in curvilinear fash-
ion, you can do that. It does require more mobilization of the
peritoneum on the posterior side of the diaphragm and does sub-
ject a patient to an increased risk, theoretically, of a splenic injury.
We have not seen that, but theoretically, it is possible. 
You mentioned the single graft configurations that we used
in a parallel fashion. You can take them off as a branch point, as
you saw, for renal artery bypass. We find it slightly easier and have
more latitude in how the grafts lie if we do two single grafts. The
aortic side-biting clamp that we use you can easily fit two 8-mm
grafts if need be. We typically use an 8- and a 6-mm graft. By
checking with a handheld continuous wave Doppler, we do
ensure that you have prograde flow. Theoretically, that should
minimize your risk of having spinal cord ischemia from placing a
thoracic clamp on the aorta but would technically never be zero,
but I’d try to limit that as much as possible because it would be a
devastating complication to have.
Dr G. Patrick Clagett (Dallas, Tex). We’ve utilized this
approach, but mainly when the supraceliac aorta was unavailable
for use for other reasons, such as previous operations or extensive
disease. And my question is, why not use the supraceliac aorta?
It’s, I think, a much simpler operation. It’s readily available, and
you avoid the thoracotomy and a lot of the problems that you
mentioned. How many of these patients would have been
amenable to a supraceliac aortomesenteric bypass?
Dr Farber. Not having participated in all the patients, I can’t tell
you. From their angiographic evaluation, I would say a small num-
ber, probably 15% to 20% of them, would not have been suitable
for a supraceliac clamp in that region. Theoretically, as you know,
that would submit the patient to some risk of spinal cord ischemia.
There is some theoretical advantage to using thoracic aorta.
We all know that supraceliac disease exists. Maybe the reason why
some grafts fail with supraceliac or infrarenal bypass grafting is that
progression of inflow disease. The thoracic aorta is less prone to
atherosclerosis, and maybe by providing inflow for your grafts from
this area, we don’t have those early or late thrombotic complica-
tions. The patients appear to expire of other comorbid problems,
not from thrombotic or ischemic bowel complications that occur.
Dr Porter. Certainly all of our clinical experience, I think, is
the same. The supraceliac aorta is occasionally involved in devas-
tating atherosclerosis that we almost never see in the thoracic
aorta. I have to interject that.
Dr Kenneth Ouriel (Cleveland, Ohio). I agree wholeheartedly
with the findings of the UNC group. I think an antegrade bypass
is better than a retrograde bypass. And I also agree that the
descending thoracic aorta is a good inflow site. But a thora-
cotomy through the ninth inner space is certainly not the only
way and not my preference for exposing that segment of aorta.
With a mechanical retractor, resection of the 11th rib, and divi-
sion of the crura of the diaphragm, there is no reason that one
couldn’t approach the segment of aorta that we saw in your pic-
tures through a purely retroperitoneal procedure. I wonder if
you’ve considered using that approach instead of a thoracotomy
in these sometimes frail and medically compromised patients. 
Dr Farber. We have not considered a purely retroperitoneal
approach. We will do thoracic exposures for our neurosurgical
and our orthopedic colleagues quite frequently. I don’t know that
resecting a rib is that much better than the thoracotomy. As I
mentioned, 10 of the 18 patients were intubated immediately
after the procedure, and we’ve not had any significant pulmonary
complications, but we will consider that. Thank you. 
Dr Hugh G. Beebe (Toledo, Ohio). I thought Dr Clagett
was going to enumerate the advantages of the supraceliac
approach in a more detailed way, and I just wanted to offer the
advantages as an alternative. You can go a surprising distance up
the thoracic aorta from a small upper midline laparotomy by
opening the aortic hiatus of the diaphragm. So it’s an antegrade
thoracic bypass graft with no thoracotomy, which is pretty mor-
bid, with no incision taking down the diaphragm, which can be
morbid, and with only two anastomoses both the celiac and
superior mesenteric arteries can be reconstructed with a single
bypass graft, as we have previously reported with similar out-
comes in a similar size series. So I just wanted to offer that as an
alternative and ask whether in your institution you have any con-
sideration of that approach? 
Dr Farber. The times that we have used that approach have
been in patients who have not presented with classic mesenteric
ischemia symptoms but with median arcuate ligament syndrome.
That’s where we utilize that approach. We’ve used it that way and
via a thoracoabdominal approach, so that we can resect all that
associated tissue.
I personally don’t have any personal experience doing a
supraceliac bypass. I find that’s working in a smaller area. The
exposure here is wide open, and there is no problem with how the
grafts lie, putting clamps, or any other problems. You don’t have
any problem with potential disease of the supraceliac aorta. So we
have not chosen that approach; maybe that’s due to our familiar-
ity and extensive use of the thoracic aortic for mesenteric bypasses
and for thoracobifemoral bypasses. Thank you.
Dr John E. Connolly (Irvine, Calif). I’d like to congratulate
the authors on their excellent results.
Dr Stoney, I believe, was the first to show that the distal tho-
racic aorta can be reached through an abdominal midline
approach, and I would like the authors to comment on that as
opposed to their approach.
Also, your approach described today is not dissimilar to that
required for the trapdoor endarterectomy of the origins of mesen-
teric vessels; perhaps yours is even a little greater in magnitude.
The criticism of that operation has been that the retroperi-
toneal approached is too complicated and secondly, that you have
to temporarily clamp the aorta above the kidneys. We find that
the endarterectomy is very similar to a carotid endarterectomy. It
doesn’t take any longer. And if you put a little ice in the abdomen,
you have at least 60 minutes of safe renal artery ischemia.
The advantage of this operation is that all of the occlusive dis-
ease is removed without the need for any bypasses, which can sub-
sequently occlude. Since the operative approach is no more
extensive than that described today, we favor the trapdoor
endarterectomy procedure for mesenteric ischemia and wonder if
the authors have tried it or have an opinion of it. 
Dr Farber. We don’t use that particular approach. I think that
you can use it if you are very facile with endarterectomy. I think
one adjuvant that has not been talked about that the group from
Bowman Gray utilizes is duplex scanning after you complete an
endarterectomy. They use it mainly for renal revascularization,
but I think if you’re going to do that, I would make sure that
some intraoperative evaluation of the distal end points be done.
This may be one way to avoid some problems. We have not used
that particular approach, however. 
Dr Sateesh C. Babu (Valhalla, NY). I would like to just express
the opposite point of view. We have used iliac artery exclusively as
the inflow because these patients, at least in our institution, are
very old and nutritionally depleted. They are also having COPD
and don’t tolerate thoracotomy very well. And about 2 or 3 years
ago we presented our experience, and we haven’t had any chance
to repent it or regret it. The iliac artery, provided the aortoiliac
system is patent, works very well as the inflow, and the blood flow
in retrograde to the superior mesenteric artery hasn’t had any
problem in our experience, at least. The operation is simple and
can be done very quickly.
Dr Farber. I’ll take your comments in two parts. One part is
the debilitated thoracotomy perception. I think when you use a
thoracic epidural along with the advancements in anesthesia,
especially in the last 10 years, I think one sees significantly less
complications associated with a thoracotomy. A low thoracotomy
is not anywhere near as morbid as an upper thoracotomy, and it’s
extremely well tolerated using these adjuvants.
In terms of the iliac vessel–based bypasses or retrograde
bypasses, you do have progression of disease, as we all know.
Many of these patients, as you saw in our paper, had previous
abdominal surgery, which can add to potential complications.
The kinking issue that Dr Porter’s group has described and
avoided by using a general curve is difficult to perform, in my
opinion. But then again I don’t have the experience that Dr
Porter does. So I would just prefer to use our approach. In our
practice we have a significant experience with the thoracic aorta,
which facilitates this surgical approach.
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